Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes Care 29:2268-2274, 2006
DOI: 10.2337/dc06-0243
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Korf, E. S.C.
Right arrow Articles by Launer, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Korf, E. S.C.
Right arrow Articles by Launer, L. J.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Pathophysiology/Complications
Original Article

Brain Aging in Very Old Men With Type 2 Diabetes

The Honolulu-Asia Aging Study

Esther S.C. Korf, MD1, Lon R. White, MD2, Ph Scheltens, PHD, MD1 and Lenore J. Launer, PHD1

1 Neurology and Alzheimer Center, Vrije Universiteit Medical Center, De Boelelaan, Amsterdam, the Netherlands
2 Pacific Research Institute of Health, Honolulu, Hawaii
3 Laboratory of Epidemiology, Demography, and Biometry, National Institute on Aging, National Institutes of Health, Bethesda, Maryland

Address correspondence and reprint requests to Lenore J. Launer, Laboratory of Epidemiology, Demography, and Biometry, NIA, 7201 Wisconsin Ave., Room 3C-309, Bethesda, MD 20892. E-mail: launerl{at}nia.nih.gov

OBJECTIVE—Type 2 diabetes leads to cognitive impairment and dementia, which may reflect microvascular and macrovascular complications as well as neurodegenerative processes. There are few studies on the anatomical basis for loss of cognitive function in type 2 diabetes. The objective of this study was to investigate the association between type 2 diabetes and markers of brain aging on magnetic resonance images, including infarcts, lacunes, and white matter hyperintensities as markers of vascular damage and general and hippocampal atrophy as markers of neurodegeneration in Japanese-American men born between 1900 and 1919 and followed since 1965 in the Honolulu-Asia Aging Study.

RESEARCH DESIGN AND METHODS—Prevalent and incident dementia was assessed. Associations between magnetic resonance imaging markers and diabetic status were estimated with logistic regression, controlling for sociodemographic and other vascular factors.

RESULTS—The prevalence of type 2 diabetes in the cohort is 38%. Subjects with type 2 diabetes had a moderately elevated risk for lacunes (odds ratio [OR] 1.6 [95% CI 1.0–2.6]) and hippocampal atrophy (1.7 [0.9–2.9]). The risk for both hippocampal atrophy and lacunes/infarcts was twice as high in subjects with compared with those without type 2 diabetes. Among the group with type 2 diabetes, those with the longest duration of diabetes, those taking insulin, and those with complications had relatively more pathologic brain changes.

CONCLUSIONS—There is evidence that older individuals with type 2 diabetes have an elevated risk for vascular brain damage and neurodegenerative changes. These pathological changes may be the anatomical basis for an increased risk of cognitive impairment or dementia in type 2 diabetes.

Abbreviations: ABI, ankle-brachial index • apo, apolipoprotein • CHD, coronary heart disease • FOV, field of view • HAAS, Honolulu-Asia Aging Study • IDE, insulin-degrading enzyme • IGT, impaired glucose tolerance • MRI, magnetic resonance imaging • NFT, neurofibrillary tangle • TICV, total intracranial volume • WMH, white matter hyperintensity


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
C. Qiu, M. F. Cotch, S. Sigurdsson, M. Garcia, R. Klein, F. Jonasson, B. E.K. Klein, G. Eiriksdottir, T. B. Harris, M. A. van Buchem, et al.
Retinal and Cerebral Microvascular Signs and Diabetes: The Age, Gene/Environment Susceptibility-Reykjavik Study
Diabetes, June 1, 2008; 57(6): 1645 - 1650.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. W. Vernooij, M. A. Ikram, H. L. Tanghe, A. J.P.E. Vincent, A. Hofman, G. P. Krestin, W. J. Niessen, M. M.B. Breteler, and A. van der Lugt
Incidental Findings on Brain MRI in the General Population
N. Engl. J. Med., November 1, 2007; 357(18): 1821 - 1828.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
D. Last, D. C. Alsop, A. M. Abduljalil, R. P. Marquis, C. de Bazelaire, K. Hu, J. Cavallerano, and V. Novak
Global and Regional Effects of Type 2 Diabetes on Brain Tissue Volumes and Cerebral Vasoreactivity
Diabetes Care, May 1, 2007; 30(5): 1193 - 1199.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.